OTCM
BBBT
Market cap0kUSD
May 27, Last price
0.00USD
1D
-99.00%
IPO
-100.00%
Name
Black Bird Biotech Inc
Chart & Performance
Profile
Black Bird Biotech Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. The company also manufactures and sells CBD Oils, gummies and pet treats, CBD-infused personal care products, and hand sanitizer gel and spray products under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program. The company was formerly known as Digital Development Partners, Inc. and changed its name to Black Bird Biotech, Inc. in June 2021. Black Bird Biotech, Inc. is based in Flower Mound, Texas.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|
2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||
Revenues | 83 -20.96% | |||||||
Cost of revenue | 1,282 | |||||||
Unusual Expense (Income) | ||||||||
NOPBT | (1,199) | |||||||
NOPBT Margin | ||||||||
Operating Taxes | 370 | |||||||
Tax Rate | ||||||||
NOPAT | (1,570) | |||||||
Net income | (2,029) -3.22% | |||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 63 | |||||||
BB yield | -25.40% | |||||||
Debt | ||||||||
Debt current | 670 | |||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | 774 | |||||||
Net debt | 624 | |||||||
Cash flow | ||||||||
Cash from operating activities | (1,033) | |||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | 577 | |||||||
FCF | (1,413) | |||||||
Balance | ||||||||
Cash | 44 | |||||||
Long term investments | 1,000 | |||||||
Excess cash | 41 | |||||||
Stockholders' equity | (3,969) | |||||||
Invested Capital | 3,989 | |||||||
ROIC | ||||||||
ROCE | ||||||||
EV | ||||||||
Common stock shares outstanding | 330,728 | |||||||
Price | 0.00 -96.67% | |||||||
Market cap | 248 -94.33% | |||||||
EV | 872 | |||||||
EBITDA | (1,110) | |||||||
EV/EBITDA | ||||||||
Interest | 371 | |||||||
Interest/NOPBT |